Pretzell, I., Desuki, A., Bleckmann, A., Loges, S., Reinacher-Schick, A., Westphalen, C. B., & Lange, S. (2024). What do German Molecular Tumor Boards recommend in patients with PIK3CA-mutated tumors?: Launch and first results from the German Transsectoral Molecular Tumor Board exchange platform Deutschland. Oncology research and treatment, 47(9), . https://doi.org/10.1159/000539217
Chicago-Zitierstil (17. Ausg.)Pretzell, Ina, Alexander Desuki, Annalen Bleckmann, Sonja Loges, Anke Reinacher-Schick, C. Benedikt Westphalen, und Sebastian Lange. "What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-mutated Tumors?: Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland." Oncology Research and Treatment 47, no. 9 (2024). https://doi.org/10.1159/000539217.
MLA-Zitierstil (9. Ausg.)Pretzell, Ina, et al. "What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-mutated Tumors?: Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland." Oncology Research and Treatment, vol. 47, no. 9, 2024, https://doi.org/10.1159/000539217.